The Deadly Assassin Robin novel Chapter 1154

Robin stared at the bottle of Caffepan, deep in thought.

"The struggle between drug investors and patients needs a mediator to find balance.

"In theory, local governments should step in to solve this issue.

"If they did, they could both protect pharmaceutical companies' profits and make medicine affordable, ultimately saving lives."

Robin shook his head helplessly and continued, "Criele, for instance, is known as the world's hub for low-cost generic drugs.

"In Draconia, a bottle of the patented drug Caffepan costs 40,000 dollars, while in Criele, it's only 200 dollars—and it's legal. Many nations rely on their pharmaceutical products.

"Criele has turned into the world's drug manufacturing hub due to its use of compulsory licensing for patents.

"Countries such as Autreynia manage drug-patient relationships through patent monopoly regulations.

"These enforced measures can provide a temporary solution to the high cost of life-saving medications, offering patients a chance to extend their lives affordably.

"International patent law includes a unique clause that allows for compulsory licensing of pharmaceutical patents for public health reasons.

"Putting market rules aside and looking at this from a humanitarian angle, patent laws in the pharmaceutical field sometimes make exceptions for patents related to life-saving treatments. This perspective is rooted in the goal of treating illnesses and saving lives.

"Criele's approach is to enforce compulsory licensing on health-related patents. While this method is somewhat forceful and does harm the interests of patent holders to an extent, it has given many critically ill patients a chance to live longer.

"This strategy has earned genuine praise and widespread support from people across different countries and regions.

"Nations like Draconia and Elaria, although they also allow compulsory licensing of patents, have never put it into practice.

"They prioritize protecting patent holders' rights and fostering a healthy environment for new drug research.

"As a result, relevant authorities strictly monitor the safety and reliability of medications.

"Domestic drug laws also require that imported medicines undergo review by the drug regulatory department.

"Since drugs like Caffepan, made by Criele, don't receive import certificates, they're treated as counterfeit if they enter the country.

"This operation reflects the well-established legal systems in these regions.

"In contrast, places like Criele, where the legal framework is less clear, directly permit the production and export of generic drugs. This policy helps many patients who can't afford original medications by giving them access to cheaper alternatives that extend their lives.

"However, over time, it could discourage pharmaceutical developers from creating new drugs.

"Developed nations with robust legal systems aim to safeguard patent holders of life-saving drugs. But the downside is the steep cost of patented medications, which many patients simply can't afford.

"Some families end up financially ruined, and for those without the means to pay for treatment, giving up on life becomes their only option."

Robin let out a sigh. "Isn't this situation heartbreaking? Solving this problem isn't difficult.

"The government could purchase the patent rights for these new drugs directly and then sell them at a reduced price, allowing patients to afford their treatment. Over time, the investment made to buy the patents could be recovered.

Verify captcha to read the contentVerify